These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 20648558)

  • 1. Cilengitide inhibits progression of experimental breast cancer bone metastases as imaged noninvasively using VCT, MRI and DCE-MRI in a longitudinal in vivo study.
    Bäuerle T; Komljenovic D; Merz M; Berger MR; Goodman SL; Semmler W
    Int J Cancer; 2011 May; 128(10):2453-62. PubMed ID: 20648558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cilengitide inhibits metastatic bone colonization in a nude rat model.
    Bretschi M; Merz M; Komljenovic D; Berger MR; Semmler W; Bäuerle T
    Oncol Rep; 2011 Oct; 26(4):843-51. PubMed ID: 21725616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cilengitide affects tumor compartment, vascularization and microenvironment in experimental bone metastases as shown by longitudinal ¹⁸F-FDG PET and gene expression analysis.
    Bretschi M; Cheng C; Witt H; Dimitrakopoulou-Strauss A; Strauss LG; Semmler W; Bäuerle T
    J Cancer Res Clin Oncol; 2013 Apr; 139(4):573-83. PubMed ID: 23229276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-induced vessel remodeling in bone metastases as assessed by dynamic contrast enhanced magnetic resonance imaging and vessel size imaging: a longitudinal in vivo study.
    Bäuerle T; Merz M; Komljenovic D; Zwick S; Semmler W
    Clin Cancer Res; 2010 Jun; 16(12):3215-25. PubMed ID: 20530698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging anti-angiogenic treatment response with DCE-VCT, DCE-MRI and DWI in an animal model of breast cancer bone metastasis.
    Bäuerle T; Bartling S; Berger M; Schmitt-Gräff A; Hilbig H; Kauczor HU; Delorme S; Kiessling F
    Eur J Radiol; 2010 Feb; 73(2):280-7. PubMed ID: 19070445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-modal imaging of angiogenesis in a nude rat model of breast cancer bone metastasis using magnetic resonance imaging, volumetric computed tomography and ultrasound.
    Bäuerle T; Komljenovic D; Berger MR; Semmler W
    J Vis Exp; 2012 Aug; (66):e4178. PubMed ID: 22929330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative contrast-enhanced ultrasound for imaging antiangiogenic treatment response in experimental osteolytic breast cancer bone metastases.
    Merz M; Komljenovic D; Semmler W; Bäuerle T
    Invest Radiol; 2012 Jul; 47(7):422-9. PubMed ID: 22659593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of treatment response of cilengitide in an experimental model of breast cancer bone metastasis using dynamic PET with 18F-FDG.
    Cheng C; Komljenovic D; Pan L; Dimitrakopoulou-Strauss A; Strauss L; Bäuerle T
    Hell J Nucl Med; 2011; 14(1):15-20. PubMed ID: 21512659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cilengitide targeting of alpha(v)beta(3) integrin receptor synergizes with radioimmunotherapy to increase efficacy and apoptosis in breast cancer xenografts.
    Burke PA; DeNardo SJ; Miers LA; Lamborn KR; Matzku S; DeNardo GL
    Cancer Res; 2002 Aug; 62(15):4263-72. PubMed ID: 12154028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bevacizumab inhibits breast cancer-induced osteolysis, surrounding soft tissue metastasis, and angiogenesis in rats as visualized by VCT and MRI.
    Bäuerle T; Hilbig H; Bartling S; Kiessling F; Kersten A; Schmitt-Gräff A; Kauczor HU; Delorme S; Berger MR
    Neoplasia; 2008 May; 10(5):511-20. PubMed ID: 18472968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusion-weighted imaging and dynamic contrast-enhanced MRI of experimental breast cancer bone metastases--a correlation study with histology.
    Merz M; Seyler L; Bretschi M; Semmler W; Bäuerle T
    Eur J Radiol; 2015 Apr; 84(4):623-30. PubMed ID: 25641009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The αVβ3/αVβ5 integrin inhibitor cilengitide augments tumor response to melphalan isolated limb perfusion in a sarcoma model.
    Ten Hagen TL; Seynhaeve AL; de Wiel-Ambagtsheer Ga; de Bruijn EA; van Tiel ST; Ruegg C; Meyring M; Grell M; Goodman SL; Eggermont AM
    Int J Cancer; 2013 Jun; 132(11):2694-704. PubMed ID: 23152080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting αvβ3 and αvβ5 integrins inhibits pulmonary metastasis in an intratibial xenograft osteosarcoma mouse model.
    Gvozdenovic A; Boro A; Meier D; Bode-Lesniewska B; Born W; Muff R; Fuchs B
    Oncotarget; 2016 Aug; 7(34):55141-55154. PubMed ID: 27409827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrin alpha v beta 3 antagonist Cilengitide enhances efficacy of radiotherapy in endothelial cell and non-small-cell lung cancer models.
    Albert JM; Cao C; Geng L; Leavitt L; Hallahan DE; Lu B
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1536-43. PubMed ID: 16863930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic contrast-enhanced micro-computed tomography correlates with 3-dimensional fluorescence ultramicroscopy in antiangiogenic therapy of breast cancer xenografts.
    Pöschinger T; Renner A; Eisa F; Dobosz M; Strobel S; Weber TG; Brauweiler R; Kalender WA; Scheuer W
    Invest Radiol; 2014 Jul; 49(7):445-56. PubMed ID: 24598441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential microstructure and physiology of brain and bone metastases in a rat breast cancer model by diffusion and dynamic contrast enhanced MRI.
    Budde MD; Gold E; Jordan EK; Frank JA
    Clin Exp Metastasis; 2012 Jan; 29(1):51-62. PubMed ID: 22042553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The integrin inhibitor cilengitide affects meningioma cell motility and invasion.
    Wilisch-Neumann A; Kliese N; Pachow D; Schneider T; Warnke JP; Braunsdorf WE; Böhmer FD; Hass P; Pasemann D; Helbing C; Kirches E; Mawrin C
    Clin Cancer Res; 2013 Oct; 19(19):5402-12. PubMed ID: 23948974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoporosis influences osteogenic but not angiogenic response during bone defect healing in a rat model.
    Liu Y; Cao L; Ray S; Thormann U; Hillengass J; Delorme S; Schnettler R; Alt V; Bäuerle T
    Injury; 2013 Jul; 44(7):923-9. PubMed ID: 23522092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of bone metastasis induced by MDA-MB-231 breast cancer cells with an antibody against bone sialoprotein.
    Bäuerle T; Peterschmitt J; Hilbig H; Kiessling F; Armbruster FP; Berger MR
    Int J Oncol; 2006 Mar; 28(3):573-83. PubMed ID: 16465361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone metastasis imaging with SPECT/CT/MRI: a preclinical toolbox for therapy studies.
    Sanches PG; Peters S; Rossin R; Kaijzel EL; Que I; Löwik CW; Grüll H
    Bone; 2015 Jun; 75():62-71. PubMed ID: 25680341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.